2009-01-13 00:16:03 -

King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast of its presentation scheduled for Wednesday, January 14, 2009, beginning at 1:30 p.m. Pacific Standard Time (4:30 p.m. Eastern Standard Time), at the 27th Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California. The presentation may include a discussion of the Company's marketed

products, pipeline, strategy for growth, financial results and expectations, and other matters relating to its business. Interested persons may access the live webcast via the internet on the King Pharmaceuticals website at www.kingpharm.com/webcasts/. A replay of the webcast may be accessed at this same link for a period of not less than 30 days after the live event.


About King Pharmaceuticals


King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience, hospital and acute care. King is also a leader in the development, registration, manufacturing and marketing of pharmaceutical products for food producing animals.


Forward-looking Statements


This release contains forward-looking statements which reflect management's current views of future events and operations, including, but not limited to, statements pertaining to the anticipated webcast of the Company's presentation on January 14, 2009. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. An important factor which may cause results to differ is whether King is able to webcast the presentation on January 14, 2009 as currently planned. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.


EXECUTIVE OFFICES


KING PHARMACEUTICALS ? 501 FIFTH STREET, BRISTOL, TENNESSEE 37620





King Pharmaceuticals, Inc.

James E. Green, 423-989-8125

Executive Vice President, Corporate Affairs

or

David E. Robinson, 423-989-7045

Senior Director, Corporate Affairs